Praxis Precision Medicines, Inc. PRAX Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s total liabilities & equity?
- Praxis Precision Medicines, Inc. (PRAX) reported total liabilities & equity of $1.46B in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s total liabilities & equity changed year-over-year?
- Praxis Precision Medicines, Inc.'s total liabilities & equity increased by 205.0% year-over-year, from $478.74M to $1.46B.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total liabilities & equity has grown at a 25.3% compound annual growth rate (CAGR), from $303.18M to $937.91M.